Mice Without CB1 Receptors Are Protected from Inflammation-Induced Preterm Birth | Research

The takeaway

Knocking out the CB1 cannabinoid receptor significantly reduced preterm birth rates in mice exposed to inflammation, identifying CB1 as a potential target for preterm birth prevention.

Reproductive biologists, maternal-fetal medicine specialists, preterm birth researchers

What the researchers found

CB1-knockout mice showed significantly lower preterm birth rates compared to wild-type when exposed to LPS-induced inflammation. CB1 deficiency modulated endogenous lipids, reduced inflammatory markers (PGE2, PGF2α, MMP9), and altered fatty acid profiles in decidual tissue. Free fatty acids increased in wild-type decidua with inflammation but were unchanged in CB1-KO.

Why it matters

Preterm birth affects about 10% of pregnancies worldwide and is a leading cause of neonatal death. Identifying CB1 as a mediator of inflammation-induced preterm birth opens a new therapeutic target — though cannabis use during pregnancy remains contraindicated.

The numbers in context

CB1-KO: significantly lower PTB rates vs. wild-type. CB1-KO had lower basal FAAH activity. LPS elevated PGE2, PGF2α, and MMP9 in wild-type but not CB1-KO. Free fatty acids increased with LPS in wild-type only.

How the study worked

CB1-knockout and wild-type pregnant mice were treated with lipopolysaccharide to induce preterm birth. Decidual tissue analyzed for endocannabinoid system components, lipid profiles, and inflammatory markers including prostaglandins and matrix metalloproteinases.

What this study cannot tell us

Mouse model with LPS-induced inflammation is one of many preterm birth mechanisms. Complete CB1 knockout may not reflect pharmacological CB1 modulation. Decidual tissue analysis may not capture all relevant reproductive tissues. Human translation uncertain.

How to read the evidence

Well-designed preclinical study with mechanistic evidence, but mouse preterm birth models have limited direct human clinical translation.

When this study was published

Published 2026, identifying a new endocannabinoid system role in pregnancy.

The bigger picture

This finding is a double-edged sword for cannabis science: while it identifies CB1 as a preterm birth target, it also implies that activating CB1 (which cannabis does) could promote preterm labor — reinforcing concerns about cannabis use during pregnancy.

Questions still open

Would CB1 antagonists prevent preterm birth in humans? Does cannabis use during pregnancy increase preterm birth risk through this mechanism? Could selective peripheral CB1 blockers be safe during pregnancy?

Common questions

Is the endocannabinoid system involved in preterm birth?

Yes — this study found that removing the CB1 cannabinoid receptor significantly protected mice from inflammation-induced preterm birth, identifying the endocannabinoid system as a mediator of preterm labor.

Does this mean cannabis causes preterm birth?

The study suggests that CB1 receptor activation (which cannabis does) promotes inflammatory pathways that can lead to preterm labor. While this doesn't prove cannabis causes preterm birth, it provides a mechanistic reason to be cautious about cannabis use during pregnancy.

Read the original research

Cannabinoid receptor type 1 deficiency protects from lipopolysaccharide-induced preterm birth: the role of the decidual endocannabinoid system.

Reproduction (Cambridge, England), 171(2)

View on PubMed ↗Publisher’s paper ↗

Citation

Marvaldi, Carolina; Mirón Granese, Ayelén A; Johnson, Clare; Schander, Julieta A; Aisemberg, Julieta; Cella, Maximiliano; Correa, Fernando; Franchi, Ana M; Bradshaw, Heather B; Wolfson, Manuel L. (2026). Cannabinoid receptor type 1 deficiency protects from lipopolysaccharide-induced preterm birth: the role of the decidual endocannabinoid system.. Reproduction (Cambridge, England), 171(2). https://doi.org/10.1093/reprod/xaaf022